NOF EUROPE
   
FUNCTIONAL FOODS

Business Overview
Since the start of food-related operations in 1917, NOF's Functional Foods Business has been a pioneer in the industry by pushing forward the innovative development of technologies used in the refining and processing of edible oil and fats. Today, after steadily building a wider presence in the industry, the Functional Foods Business is active in two main areas: the edible oils business and the health-related business.

In the edible oil business, NOF widely supports the food industry by supplying products such as margarine, shortening, confectionary oils, depanning oils, fillings and toppings, oil and fat powders, and ingredients for processed foods. The business also works to develop products that take taste to a new level by leveraging technologies fostered during its time as a pioneer in oils and fats processing.

In the health-related business, NOF drives forward research into technologies that help to improve the health of society. Efforts focus on areas such as functional lipids, nano-emulsion products, micro-encapsulated products and enteral nutritional products, resulting in a stream of new products.

NOF's Functional Foods Business will continue to contribute to society by supplying products that help to create a rich choice of tasty and healthy foods.

For more details, please visit NOF CORPORATION web site.
http://www.nof.co.jp/english/business/food/index.html

 








What's New
DDS

2010/07/26 Program for Liposome Conference in Vancouver, Aug 4-8, 2010
PDF

2010/07/08 NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010

2010/06/30
NOF release New Activated PEG

2010/05/21 NOF AMERICA CORPORATION opened a new office in California

On May 7, NOF AMERICA CORPORATION, a wholly owned subsidiary of NOF,
opened a new office in California to further enhance its sales
activities in the North American market
Post Address: 2102 Business Center Drive, Suite 130 Irvine, CA 92612, USA

2010/03/11 NOF partners with ENZON on PEG derivatives PDF

2010/01/07 NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery PDF